药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Dacarbazine
Rindopepimut
The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Dasatinib.
Dacarbazine
INGN 225
The therapeutic efficacy of INGN 225 can be decreased when used in combination with Dasatinib.
Dacarbazine
PEV3A
The therapeutic efficacy of PEV3A can be decreased when used in combination with Dasatinib.
Dacarbazine
G17DT
The therapeutic efficacy of G17DT can be decreased when used in combination with Dasatinib.
Dacarbazine
Osimertinib
The serum concentration of Dasatinib can be decreased when it is combined with Osimertinib.
Dacarbazine
Terodiline
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Terodiline.
Dacarbazine
Macimorelin
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Macimorelin.
Dacarbazine
Ivabradine
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Ivabradine.
Dacarbazine
Tetrabenazine
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Tetrabenazine.
Dacarbazine
Lithium cation
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Lithium cation.
Dacarbazine
Encorafenib
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Encorafenib.
Dacarbazine
Emedastine
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Emedastine.
Dacarbazine
Dexverapamil
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Dexverapamil.
Dacarbazine
Penfluridol
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Penfluridol.
Dacarbazine
Otilonium
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Otilonium.
Dacarbazine
Dexchlorpheniramine maleate
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Dexchlorpheniramine maleate.
Dacarbazine
Eperisone
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Eperisone.
Dacarbazine
Fendiline
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Fendiline.
Dacarbazine
Bedaquiline
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Bedaquiline.
Dacarbazine
Fluspirilene
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Fluspirilene.